This company has been marked as potentially delisted and may not be actively trading. NASDAQ:SMLR Semler Scientific (SMLR) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Semler Scientific Stock (NASDAQ:SMLR) Get Semler Scientific alerts:Sign Up Key Stats Today's Range$20.27▼$21.3950-Day Range$15.21▼$22.5152-Week Range$14.89▼$50.44Volume1.62 million shsAverage Volume895,814 shsMarket Capitalization$310.74 millionP/E Ratio7.31Dividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview Semler Scientific, Inc., headquartered in Princeton, New Jersey, is a medical technology company specializing in the development and commercialization of non-invasive monitoring solutions for intracranial pressure. The company’s core focus is on improving patient care in neurocritical and acute care settings by providing clinicians with advanced diagnostic tools that reduce the risks associated with invasive procedures. The company’s flagship product, the NICO Monitor, employs proprietary acoustic monitoring technology to continuously estimate intracranial pressure and compliance at the bedside. By placing a small, ear-canal sensor on the patient, the system captures and analyzes low-frequency sound waves generated within the skull, offering real-time insights without the need for surgical implantation of pressure sensors. This non-invasive approach is designed to support faster clinical decision-making and may help reduce complications linked to invasive intracranial monitoring techniques. Since its founding in the mid-2000s, Semler Scientific has secured regulatory clearances, including FDA 510(k) approval for use in the United States, and has worked with leading hospitals and health systems to integrate its technology into neurocritical care protocols. The company continues to collaborate with clinical investigators and pursue additional regulatory pathways to broaden the use of its monitoring platform across other patient populations and geographies. Led by a management team with backgrounds in biomedical engineering, neurosurgery and commercial strategy, Semler Scientific emphasizes innovation in point-of-care monitoring. Its leadership continues to engage with clinicians, researchers and strategic partners to expand the clinical utility and adoption of its non-invasive intracranial pressure monitoring solutions worldwide.AI Generated. May Contain Errors. Read More Receive SMLR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Semler Scientific and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SMLR Stock News HeadlinesBitcoin treasury firm Strive raises $225 million to pay off loans, buy more bitcoinJanuary 30, 2026 | finance.yahoo.comSemler Scientific Closes Merger and Delisting with StriveJanuary 18, 2026 | theglobeandmail.comHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. One day it's a ceasefire, the next it's bombs again. The back and forth may be masking a bigger story most investors are missing. See the real reason this conflict may never fully end. | Banyan Hill Publishing (Ad)Vivek Ramaswamy-backed Strive and Semler stocks rebound on Bitcoin recovery after reverse split shockJanuary 14, 2026 | msn.comSemler outperforms crypto equities while Bitcoin slips below $91,000January 8, 2026 | msn.comASST Stock Performance Comes Into Question Amid Semler Scientific and Strive Merger ProspectsDecember 30, 2025 | finance.yahoo.comSemler Scientific Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Semler Scientific, Inc. - SMLRDecember 12, 2025 | prnewswire.comStrive Starts $500M Preferred Stock 'At-The-Market' Program for Bitcoin PurchasesDecember 10, 2025 | finance.yahoo.comSee More Headlines SMLR Stock Analysis - Frequently Asked Questions How were Semler Scientific's earnings last quarter? Semler Scientific Inc. (NASDAQ:SMLR) announced its quarterly earnings results on Wednesday, November, 12th. The company reported $1.07 EPS for the quarter, topping analysts' consensus estimates of ($0.15) by $1.22. The firm earned $7.49 million during the quarter, compared to analysts' expectations of $7.87 million. Semler Scientific had a net margin of 130.80% and a trailing twelve-month return on equity of 34.21%. When did Semler Scientific IPO? Semler Scientific (SMLR) raised $12 million in an initial public offering (IPO) on Friday, February 14th 2014. The company issued 1,430,000 shares at $7.50-$9.50 per share. What other stocks do shareholders of Semler Scientific own? Based on aggregate information from My MarketBeat watchlists, some other companies that Semler Scientific investors own include NVIDIA (NVDA), Palantir Technologies (PLTR), CrowdStrike (CRWD), Fulgent Genetics (FLGT), Coinbase Global (COIN), PayPal (PYPL) and Qualcomm (QCOM). Company Calendar Last Earnings11/12/2025Today10/28/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (11m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 SMLR's financial health is in the Red zone, according to TradeSmith. SMLR has been in this zone for over 11 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:SMLR CIK1554859 Webwww.semlerscientific.com Phone877-774-4211FaxN/AEmployees120Year Founded2007Profitability EPS (Trailing Twelve Months)$2.78 Trailing P/E Ratio7.31 Forward P/E RatioN/A P/E GrowthN/ANet Income$40.90 million Net Margins130.80% Pretax Margin167.96% Return on Equity34.21% Return on Assets25.58% Debt Debt-to-Equity Ratio0.21 Current Ratio1.97 Quick Ratio1.95 Sales & Book Value Annual Sales$36.96 million Price / Sales8.41 Cash Flow$4.48 per share Price / Cash Flow4.54 Book Value$24.90 per share Price / Book0.82Miscellaneous Outstanding Shares15,285,000Free Float12,778,000Market Cap$310.74 million OptionableOptionable Beta1.32 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:SMLR) was last updated on 1/16/2026 by MarketBeat.com Staff. From Our PartnersThe cash in your checking account has a problemThere's a pile of cash sitting in your checking account, earning next to nothing while you weigh your options....Counterflow | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Withou...Behind the Markets | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredDon't lose access to thisIan Cooper's guide, 'The $50-to-$500 Options Strategy,' is still available for free download, but not for long...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Semler Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Semler Scientific With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
